// Mission Reports
Pharmaceutical & Biotech

Pharmaceutical IP Protection

ClientBiotech Research Facility
Recovery Time Objective0h
SectorPharmaceutical & Biotech
Mission Recording
Pharmaceutical IP Protection
5/5 Rating

Our vaccine research represents years of work. CryptaGuard not only protected our intellectual property but helped us work with authorities to prevent future attacks.

D

Dr. Rebecca Anderson

Chief Scientific Officer, BioGen Research

Threat Assessment

Challenge

Targeted espionage attempt to steal COVID vaccine research data and clinical trial results worth $2B.

Key Challenges:

  • !!Encrypted critical payment processing infrastructure
  • !!Potential data loss during recovery
  • !!Customer-facing systems disruption
  • !!Regulatory reporting requirements
Countermeasures Deployed

Solution

Forensic investigation with IP protection protocols, secure data validation, and enhanced access controls.

Key Solutions:

  • >>Isolated parallel recovery environment
  • >>Real-time data integrity validation
  • >>Phased restoration prioritizing critical services
  • >>Enhanced monitoring and security controls
Mission Outcome

Result

Research data fully protected, threat actors identified, collaboration with law enforcement, zero IP loss.

Recovery Time0h
Data Recovery100%
StatusResolved
[ Engage ]

Need Similar Results?

Contact our cyber-resilience experts to discuss how we can help your organization prepare for and recover from cyber incidents.

Contact Our Team